Camp4 Therapeutics Corp (CAMP) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2026-06-12

Camp4 Therapeutics Corp (CAMP) has filed 6 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-12. 3 Form 8-K material event filings were reported by CAMP in the last 90 days. InsiderAlpha tracks every CAMP SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About Camp4 Therapeutics Corp (CAMP)

SEC CIK	0001736730

90-Day SEC Filing Activity

Form 4 filings (90d)	6
Form 8-K filings (90d)	3
Latest Form 4 filing	2026-06-12

Recent CAMP Insider Transactions (Form 4)

Date	Insider	Role	Transaction	Shares	Price	Value	Filing
2025-09-11	Polaris Management Co. VII, L.L.C.	Insider	P — Open-market purchase	1.22M	$1.53	$1.87M	SEC
2025-09-11	Nashat Amir	Insider	P — Open-market purchase	85.5K	$1.53	$131K	SEC
2025-09-11	Schwab Andrew J.	Insider	A — Grant or award	2.94M	$1.53	$4.50M	SEC
2025-09-11	Polaris Management Co. VII, L.L.C.	Insider	P — Open-market purchase	85.5K	$1.53	$131K	SEC
2025-09-11	5AM Partners VI, LLC	Insider	P — Open-market purchase	2.94M	$1.53	$4.50M	SEC
2025-09-11	Young Richard A	Director	P — Open-market purchase	15.2K	$1.65	$25K	SEC
2025-09-11	Gold Kelly	Chief Financial Officer	P — Open-market purchase	6.1K	$1.65	$10K	SEC
2025-09-11	Maricich Yuri	Chief Medical Officer	P — Open-market purchase	6.1K	$1.65	$10K	SEC
2025-09-11	Mandel-Brehm Josh	Chief Executive Officer	P — Open-market purchase	6.1K	$1.65	$10K	SEC
2025-09-11	Nashat Amir	Insider	P — Open-market purchase	1.22M	$1.53	$1.87M	SEC
2024-10-15	Young Richard A	Director	J — Other acquisition / disposition	8.9K	—	—	SEC
2024-10-15	AH Equity Partners Bio I, L.L.C.	Insider	P — Open-market purchase	545.5K	$11.00	$6.00M	SEC
2024-10-15	AH Equity Partners Bio I, L.L.C.	Insider	P — Open-market purchase	181.8K	$11.00	$2.00M	SEC
2024-10-15	Holtzman Steven H	Director	J — Other acquisition / disposition	8.9K	—	—	SEC
2024-10-15	AH Equity Partners Bio I, L.L.C.	Insider	J — Other acquisition / disposition	1.40M	—	—	SEC

All transactions sourced from SEC EDGAR Form 4 filings for Camp4 Therapeutics Corp (CAMP). Updated in real time as new filings are submitted to the SEC.

Most-Active CAMP Insiders — Last 90 Days

Insider	Form 4 filings	Total transaction value
Young Richard A	1	—
Schwab Andrew J.	1	—
Nashat Amir	1	—
WILLIAMS DOUGLAS E	1	—
Holtzman Steven H	1	—

Recent CAMP Form 8-K Material Events

2026-06-12 — Item 5.02, 5.07, 9.01 [SEC]
2026-05-14 — Item 7.01, 9.01 [SEC]
2026-05-07 — Item 2.02, 9.01 [SEC]
2026-03-24 — Item 5.02 · Leadership · positive [SEC]
Camp4 Therapeutics appointed Michael MacLean as a Class III director effective April 1, 2026, expanding the board from eight to nine members. MacLean brings over 35 years of financial leadership experience in biotechnology, including recent CFO roles at Avidity Biosciences (acqui
2026-03-05 — Item 2.01, 7.01, 9.01 · Earnings · neutral [SEC]
Camp4 Therapeutics issued a press release on March 5, 2026 announcing its financial results for the year ended December 31, 2025, along with an updated corporate presentation. The filing provides standard annual financial results without indication of beat/miss relative to expect

Recent Insider Filings

2026-06-12 — WILLIAMS DOUGLAS E (Director)
2026-06-12 — Young Richard A (Director)
2026-06-12 — Schwab Andrew J. (Director)
2026-06-12 — Holtzman Steven H (Director)
2026-06-12 — Stewart Murray (Director)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in CAMP insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

CAMP Insider Trading — FAQ

What is the latest insider trade for CAMP?: Camp4 Therapeutics Corp (CAMP) had 6 insider filings in the last 90 days, with the most recent on 2026-06-12. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying CAMP stock?: 0 insider purchases of CAMP were filed in the last 90 days.
How many insiders are selling CAMP stock?: 0 insider sales of CAMP were filed in the last 90 days.
Where can I see CAMP SEC filings (Form 4, 10-K, 10-Q, 8-K)?: InsiderAlpha aggregates every CAMP SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Learn More

Open the live CAMP dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.